1463-1318/asset/olbannerleft.gif?v=1&s=9369e1737cbe25d8039ff8614102dddbfdef74d9)
1463-1318/asset/olbannerright.gif?v=1&s=5f8f0474c30cbd963d229b97160389a94f1b8016)
Colorectal Disease
© The Association of Coloproctology of Great Britain and Ireland
Edited By: R.J. Nicholls
Impact Factor: 2.58
ISI Journal Citation Reports © Ranking: 2011: 30/74 (Gastroenterology & Hepatology)
Online ISSN: 1463-1318
Recently Published Issues
Current Issue:May 2013
Volume 15, Issue 5
Volume 15, Issue 4
Volume 15, Issue 3
Volume 15, Issue 2
Volume 15, Issue 1
Most Cited
When the 2011 Impact Factor was first calculated, the two 2010 online-only issues were omitted. Following on from this, the Impact Factor has been recalculated and now stands at 2.580.
You can read the most cited papers that helped contribute to this Impact Factor online now.
Editor's Choice
Read the latest Editor's Choice paper online now.
One article from each issue of Colorectal Disease is now selected as Editor's Choice. An accompanying commentary is written by Editor Alexander Engel.
May 2013
Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer.
J. Arredondo, C. Pastor, J. Baixauli, et al.
Neo-adjuvant chemotherapy has claimed its place in the treatment of a number of locally advanced solid tumours. Current RCTs like the Foxtrot trial are examining its role in locally advanced, but operable colon cancer.
New Appointment
ESCP Representative to Colorectal Disease
Editorial Board Research Committee appointment with international trials focus
Click here to learn more
1463-1318/asset/defaultSocietyImage.jpg?v=1&s=9ef97ae7098942974d0975ab1ccce6805f0584d5)